<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0002042910</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001501796</issuerCik>
<issuerName>Aura Biosciences, Inc. </issuerName>
<secFileNumber>001-40971</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
</issuerAddress>
<issuerContactPhone>617-500-8864</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Elazzouzi Amy</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney LLC Drive</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 West Civic Center</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">4th Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">Sandy</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">UT</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">84070</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>1581</noOfUnitsSold>
<aggregateMarketValue>7683.66</aggregateMarketValue>
<noOfUnitsOutstanding>63503269</noOfUnitsOutstanding>
<approxSaleDate>01/20/2026</approxSaleDate>
<securitiesExchangeName>Nasdaq</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>01/19/2023</acquiredDate>
<natureOfAcquisitionTransaction>Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Aura Biosciences, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>2844</amountOfSecuritiesAcquired>
<paymentDate>01/19/2023</paymentDate>
<natureOfPayment>N/A</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Amy Elazzouzi</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>10/29/2025</saleDate>
<amountOfSecuritiesSold>896</amountOfSecuritiesSold>
<grossProceeds>5689.60</grossProceeds>
</securitiesSoldInPast3Months>
<remarks>The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.</remarks>
<noticeSignature>
<noticeDate>01/20/2026</noticeDate>
<signature>/s/ Amy Elazzouzi</signature>
</noticeSignature>
</formData>
</edgarSubmission>
